You are now leaving helsinn.com

Please click 'Continue to external site' if you want to continue.

News and Events

News

26 April 2023

Solna, Sweden and Lugano, Switzerland, April 13, 2022 – AnaCardio, a Swedish clinical-stage biopharmaceutical company focussed on developing novel contractile agents with a unique mode-of-action […]

3 February 2023

Lugano, Switzerland, February 3, 2023 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial […]

24 January 2023

LUGANO, Switzerland and STOCKHOLM, Sweden – January 24, 2023 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over […]

10 January 2023

Lugano, Switzerland, January 10, 2023 – Helsinn Group (“Helsinn”), a fully integrated, global biopharma company with a track record of over forty years of commercial […]

9 January 2023

Lugano, Switzerland, January 9, 2023 – Helsinn Group (“Helsinn”), a fully integrated, global biopharma company with a track record of over forty years of commercial […]

4 January 2023

Lugano, Switzerland, January 4, 2023 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial […]

29 November 2022

Lugano, Switzerland, November 29, 2022 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial […]

28 November 2022

CHIASSO, Switzerland and LUGANO, Switzerland – November 28, 2022 – Farma Mondo Group, a Swiss-based pharmaceutical group focused on providing market access and speciality distribution […]

18 October 2022

Lugano, Switzerland, October 18, 2022 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a diversified pipeline of innovative oncology assets, announces that […]

21 September 2022

Lugano, Switzerland, 21 September 2022 – Helsinn Group (“Helsinn”), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets, announces that two […]

View all news articles

Events

No events currently available